Metabiota Stock

metabiota.comHealthcareFounded: 2008Funding to Date: $42.11MM

Metabiota is a health big data tracking company providing data, analytics, advice, and training to help governments prepare for global health threats and mitigate their impacts.

Register for Details

For more details on financing and valuation for Metabiota, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Metabiota.

Register Today

Metabiota investors also invested in these private companies



Management Team

Robert Mann
COO & President
Nathan Wolfe
Founder & Chairman
James Pitkow Ph.D
Michael Bell
Mary Guttieri Ph.D
Executive Vice President

Board Members

Nathan Wolfe
John DeLoche
Riaz Valani

Other companies like Metabiota in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


In an effort to inform the public of the health risks breaking out all over the world (or just to scare the bejeezus out of already paranoid people), the startup Metabiota has released a free-to-use epidemic tracker for all of the outbreaks monitored publicly around the world. The San Francisco-bas…
The African Risk Capacity (ARC), a parametric sovereign disaster risk insurer for African nations, has begun a pilot with the help of San Francisco based Metabiota to roll-out parametric insurance cover against disease outbreaks and epidemics. The new parametric outbreak & epidemic insurance product has been coming for some time, as ARC looks to expand its remit to cover new risks which will in turn increase the diversification within and efficiency of its sovereign risk pool. Metabiota is a company focused on risk analytics for epidemics and it has just begun the risk modelling work for the new ARC outbreak and epidemic insurance product. The goal is to help African Nations to better plan for and mitigate the risk of infectious disease outbreaks within their countries, providing an insurance product that will pay out rapidly should an outbreak show signs of developing, helped by the use of parametric triggers and backed by global reinsurance capacity. The pilot phase of the